Magnetic resonance imaging as an approach towards identifying neuropathological biomarkers for Huntington's disease
- 9 April 2008
- journal article
- review article
- Published by Elsevier in Brain Research Reviews
- Vol. 58 (1) , 209-225
- https://doi.org/10.1016/j.brainresrev.2008.04.001
Abstract
No abstract availableKeywords
This publication has 95 references indexed in Scilit:
- Change in MRI striatal volumes as a biomarker in preclinical Huntington's diseaseBrain Research Bulletin, 2007
- Onset and rate of striatal atrophy in preclinical Huntington diseaseNeurology, 2004
- Caudate volume as an outcome measure in clinical trials for Huntington’s disease: a pilot studyBrain Research Bulletin, 2003
- Rate of caudate atrophy in presymptomatic and symptomatic stages of Huntington's diseaseMovement Disorders, 2000
- Frontal lobe volume in patients with Huntington's diseaseNeurology, 1998
- Cognitive deficits in Huntington's disease are predicted by dopaminergic PET markers and brain volumesBrain, 1997
- Longitudinal change in basal ganglia volume in patients with Huntington's diseaseNeurology, 1997
- Basal Ganglia Volume and Proximity to Onset in Presymptomatic Huntington DiseaseArchives of Neurology, 1996
- Reduced basal ganglia volume associated with the gene for Huntington's disease in asymptomatic at‐risk personsNeurology, 1994
- Parallel Organization of Functionally Segregated Circuits Linking Basal Ganglia and CortexAnnual Review of Neuroscience, 1986